Could a quick brain zap ease Long-Term nerve pain?
NCT ID NCT07650526
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two non-invasive brain stimulation techniques—standard rTMS and a faster version called aiTBS—against a sham (fake) treatment in 30 adults with chronic neuropathic pain lasting at least 6 months. Participants receive both active and sham treatments in a random order, with a washout period in between. The goal is to see if these methods reduce pain and to find predictors of who might benefit most.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial magnetic stimulation (TMS) - a non-invasive device that uses magnetic pulses to stimulate the brain
What this could lead to
If successful, this could offer a faster, more convenient non-drug option for managing chronic neuropathic pain.
What could go wrong
This is a small early-stage trial with only 30 participants. The effects may be modest or not last long, and not everyone may respond.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC NEUROPATHIC PAIN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hopital Ambroise-Paré INSERM U987, 9 Av. Charles de Gaulle
Boulogne-Billancourt, Île-de-France Region, 92100, France